The START Center Global Program was launched in 2011 with support from the Bill & Melinda Gates Foundation. Initially, the Program was designed to support research and analysis for program teams at the Gates Foundation. Since that time, The START Center Global Program has expanded and now provides high-quality research and analytic support for a number of additional clients.
2/10/2025
The START team conducted a systematic analysis of the representation of diagnostics in published scientific literature across 7 priority disease areas—HIV, TB, Malaria, Anemia, HPV, Non-HIV STIs and NTDs, with a focus on low- and middle-income countries (LMICs). This analysis aimed to identify gaps in diagnostics research, assess trends, and understand how investments in diagnostics align with global health priorities.
4/30/2018
In October 2016, the START Center launched the Gut Health Digest to support the Enteric and Diarrheal Diseases and Discovery teams at the Bill & Melinda Gates Foundation.
2/4/2025
The START team conducted a scoping review to map the existing literature on levonorgestrel pharmacokinetics in special population groups with pathophysiology theorized or understood to impact drug pharmacokinetics (e.g. undernutrition, liver disease, female reproductive tract abnormalities, gastrointestinal illnesses) and identify any gaps and relevant PK data in the literature.